Yi-Bin Chen, MD | Authors

March 28, 2022

Closing out his discussion, Yi-Bin Chen, MD, talks about unmet needs, ongoing clinical trials, emerging treatment options for patients with steroid-refractory chronic GVHD.

March 28, 2022

Yi-Bin Chen, MD, reflects on the patient case and outlines strategies for educating and managing patients at risk of developing chronic GVHD.

March 28, 2022

A brief overview of safety and adverse events in the REACH3 trial of ruxolitinib in patients with steroid-refractory chronic GVHD.

March 28, 2022

A discussion of data from the REACH3 trial and real-world data on the efficacy of ruxolitinib in patients with steroid-refractory chronic GVHD.

March 28, 2022

Yi-Bin Chen, MD, discusses available treatment options for patients with steroid-refractory chronic GVHD.

March 28, 2022

Insight on early diagnosis of chronic GVHD and the tools clinicians use to assess GVHD severity.